The Latin America, Middle East and Africa RNA Analysis Market would witness market growth of 19.7% CAGR during the forecast period (2022-2028).
RNA-Seq is a sequencing method that makes use of next-generation sequencing (NGS) to examine the constantly changing cellular transcriptome to determine the presence and amount of RNA in a biological sample at any given time. With the use of RNA-Seq, it is now possible to examine alternative gene spliced transcripts, gene fusions, mutations and SNPs, post-transcriptional alterations, changes in gene expression over time, and variations in gene expression among groups and therapies.
Additionally, RNA-Seq could examine several RNA populations, such as small RNA, total RNA, and ribosome profiling. Exon/intron borders and previously defined 5' and 3' gene boundaries might also be determined using RNA-Seq. The next-generation sequencing method for analyzing viral genome variability includes NA isolation and enrichment. To keep RNA from deteriorating, biological materials are purified during the RNA separation process.
As one of the Middle East's most economically developed and diversified nations, the UAE has a strong healthcare system. The UAE government has prioritized creating world-class health systems, and as a result, the industry has developed and grown significantly over the past few years. After COVID-19 broke out in January 2020, the UAE government moved right away to implement preventative health measures. The UAE is regarded as one of the best countries in the world and the highest in the Arab world in terms of COVID-19 response due to the leadership's tireless efforts.
The Brazil market dominated the LAMEA RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $473.6 million by 2028. The Argentina market is experiencing a CAGR of 20.4% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 19.4% during (2022 - 2028).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global RNA Analysis Market is Predict to reach $28 Billion by 2028, at a CAGR of 15.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.
By Product
By Technology
By End-use
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 